<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: sexual transmission</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Stigma hampering cervical cancer battle in India</title>
   	 <description>Social stigma is harming attempts to combat  cervical cancer in India where more women die annually of the disease than anywhere else in the world, a new report said Friday.</description>
     <link>http://medicalxpress.com/news/2013-05-stigma-hampering-cervical-cancer-india.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 10 May 2013 05:57:16 EST</pubDate>
	 <guid isPermaLink="false">news287384220</guid>
	 
</item>
<item>
     <title>Teens, young adults bear disproportionate share of STDs</title>
   	 <description>In the heat of the moment, it's a good bet sexually transmitted infections are the last thing on a teen's or young adult's mind. Thus, according to the Centers for Disease Control and Prevention in Atlanta, young people ages 15-24, who make up just more than one-quarter of the sexually active population, account for half of the 20 million new sexually transmitted infections that occur in the U.S. each year.</description>
     <link>http://medicalxpress.com/news/2013-04-teens-young-adults-disproportionate-stds.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 28 Apr 2013 19:20:01 EST</pubDate>
	 <guid isPermaLink="false">news286392722</guid>
	 
</item>
<item>
     <title>Gel safe and acceptable as approach to preventing HIV from anal sex</title>
   	 <description>A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally, according to a Phase I clinical trial published today in PLOS ONE. The study, led by researchers with the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), tested a reduced glycerin formulation of tenofovir gel, and has spurred the development of an expanded safety study of the gel, expected to launch later this year.</description>
     <link>http://medicalxpress.com/news/2013-04-gel-safe-approach-hiv-anal.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 03 Apr 2013 17:00:11 EST</pubDate>
	 <guid isPermaLink="false">news284215947</guid>
	 
</item>
<item>
     <title>Hong Kong sees 17-percent rise in HIV cases</title>
   	 <description>Hong Kong saw a 17-percent jump in the number of new HIV infections in 2012, driven mainly by sexual transmission, data showed Wednesday, bucking a regional trend of decline.</description>
     <link>http://medicalxpress.com/news/2013-03-hong-kong-percent-hiv-cases.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 06 Mar 2013 07:24:49 EST</pubDate>
	 <guid isPermaLink="false">news281777078</guid>
	 
</item>
<item>
     <title>New research calls for better guidance about HIV transmission and the law</title>
   	 <description>Support services for people living with HIV will benefit from better information about prosecutions for the sexual transmission of HIV, according to a report released today by researchers from Sigma Research at the London School of Hygiene &amp; Tropical Medicine, and Birkbeck, University of London.</description>
     <link>http://medicalxpress.com/news/2013-03-guidance-hiv-transmission-law.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 05 Mar 2013 19:00:04 EST</pubDate>
	 <guid isPermaLink="false">news281723817</guid>
	 
</item>
<item>
     <title>HIV exploits a human cytokine in semen to promote its own transmission</title>
   	 <description>A new report suggests that the concentration of one human cytokine, interleukin 7 (IL-7), in the semen of HIV-1-infected men may be a key determinant of the efficiency of HIV-1 transmission to an uninfected female partner. In their study published February 7 in the Open Access journal PLOS Pathogens, a research group from the Eunice Kennedy-Shriver National Institute of Child Health and Human Development (NICHD) led by Leonid Margolis report that the increased IL-7 concentration in semen facilitates HIV transmission to cervical tissue ex vivo.</description>
     <link>http://medicalxpress.com/news/2013-02-hiv-exploits-human-cytokine-semen.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 07 Feb 2013 17:00:03 EST</pubDate>
	 <guid isPermaLink="false">news279466658</guid>
	 
</item>
<item>
     <title>Vaginal microbicide gel may offer a promising strategy for prevention and protection against HIV transmission</title>
   	 <description>A new study shows that a microbicide gel is highly effective in block infection by the AIDS virus in a non-human primate model. In the paper published December 6 in the Open Access journal PLOS Pathogens, Dereuddre-Bosquet and colleagues from the European Combined Highly Active Anti-Retroviral Microbicides (CHAARM) Consortium describe the gel's key ingredient, which are small peptides engineered to present a decoy to bind up the virus and prevent it from entering and infecting the cells of the body. Because this is a gel it can be topically applied and could represent a powerful preventative agent against sexual transmission of HIV.</description>
     <link>http://medicalxpress.com/news/2012-12-vaginal-microbicide-gel-strategy-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 06 Dec 2012 17:10:02 EST</pubDate>
	 <guid isPermaLink="false">news274031729</guid>
	 
</item>
<item>
     <title>Novel intravaginal ring shows promise in HIV prevention</title>
   	 <description>A new 90-day intravaginal ring has been developed—that for the first time—enables the long-lasting vaginal delivery of tenofovir (TFV), the only topical prophylactic shown to be effective at reducing the sexual transmission of human immunodeficiency virus (HIV) when formulated in a short-lasting gel. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in Chicago, Ill., Oct. 14 – 18.</description>
     <link>http://medicalxpress.com/news/2012-10-intravaginal-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 16 Oct 2012 14:30:01 EST</pubDate>
	 <guid isPermaLink="false">news269614823</guid>
	 
</item>
<item>
     <title>UNAIDS welcomes US approval of drug to stop HIV</title>
   	 <description> The UN agency tasked with fighting AIDS on Tuesday welcomed the decision by the United States to allow the use of an HIV prevention pill for the first time.</description>
     <link>http://medicalxpress.com/news/2012-07-unaids-drug-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 17 Jul 2012 06:38:40 EST</pubDate>
	 <guid isPermaLink="false">news261725914</guid>
	 
</item>
<item>
     <title>Lessons learned from the 'ethical odyssey' of an HIV trial</title>
   	 <description>In the battle against HIV/AIDS conditions on the frontlines are constantly in flux as treatment, research and policy evolve. The landmark HIV Prevention Trials Network (HPTN) 052 study, which established that antiretroviral treatment in people who are HIV positive decreases the likelihood of transmitting HIV to their sexual partners, was no exception. One year after publication the study serves as a case study of ethical challenges faced at every stage of the research trial process in the new paper &quot;Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey,&quot; published in the June 2012 issue of Clinical Trials.</description>
     <link>http://medicalxpress.com/news/2012-06-lessons-ethical-odyssey-hiv-trial.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 14 Jun 2012 12:02:03 EST</pubDate>
	 <guid isPermaLink="false">news258894113</guid>
	 
</item>
<item>
     <title>Chinese researchers eye anti-AIDS gel</title>
   	 <description>Chinese researchers said Monday they have discovered an HIV-blocking agent that could be developed into a gel to limit the sexual transmission of AIDS.</description>
     <link>http://medicalxpress.com/news/2012-04-chinese-eye-anti-aids-gel.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 23 Apr 2012 09:15:44 EST</pubDate>
	 <guid isPermaLink="false">news254391335</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/achinesemanf.jpg" width="90" height="90" />
</item>
<item>
     <title>Will women use microbicides to protect themselves against HIV?</title>
   	 <description>Are women willing to use a vaginal gel to protect themselves against HIV infection? Researchers at The Miriam Hospital say that is the million dollar question when it comes to developing products known as microbicides that can prevent the sexual transmission of HIV.</description>
     <link>http://medicalxpress.com/news/2012-04-women-microbicides-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 19 Apr 2012 13:20:02 EST</pubDate>
	 <guid isPermaLink="false">news254058949</guid>
	 
</item>
<item>
     <title>Rectal formulation of tenofovir gel safe and acceptable in early phase clinical study</title>
   	 <description>A gel formulation of the antiretroviral drug tenofovir designed specifically for rectal use was found safe and acceptable, according to a Phase I clinical study led by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), and presented today at the 19th Conference on Retroviruses and Opportunistic Infections (CROI). The results of the study, which included HIV-negative men and women who used the gel rectally once a day for one week, serve as an important step toward the development and testing of a rectal microbicide to prevent HIV from anal sex.</description>
     <link>http://medicalxpress.com/news/2012-03-rectal-tenofovir-gel-safe-early.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 06 Mar 2012 04:20:01 EST</pubDate>
	 <guid isPermaLink="false">news250228749</guid>
	 
</item>
<item>
     <title>Targeting HIV's sugar coating: New microbicide may block AIDS virus from infecting cells</title>
   	 <description>University of Utah researchers have discovered a new class of compounds that stick to the sugary coating of the AIDS virus and inhibit it from infecting cells &amp;#150; an early step toward a new treatment to prevent sexual transmission of the virus.</description>
     <link>http://medicalxpress.com/news/2011-09-hiv-sugar-coating-microbicide-block.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 23 Sep 2011 04:13:20 EST</pubDate>
	 <guid isPermaLink="false">news235969982</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/targetinghiv.jpg" width="90" height="90" />
</item>
<item>
     <title>Could engineered fatty particles help prevent AIDS?</title>
   	 <description>Could engineered fatty particles help prevent AIDS? Liposomes block HIV infection in early tests; could be a cost-effective preventive for developing countries</description>
     <link>http://medicalxpress.com/news/2011-09-fatty-particles-aids.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 19 Sep 2011 16:48:44 EST</pubDate>
	 <guid isPermaLink="false">news235669669</guid>
	 
</item>
<item>
     <title>Hepatitis C is transmitted by unprotected sex between HIV-infected men</title>
   	 <description>Sexual transmission of hepatitis C virus (HCV) is considered rare. But a new study by researchers at Mount Sinai School of Medicine, working with the Centers for Disease Control and Prevention (CDC), provides substantial evidence that men with HIV who have sex with other men (MSM) are at increased risk for contracting HCV through sex.</description>
     <link>http://medicalxpress.com/news/2011-07-hepatitis-transmitted-unprotected-sex-hiv-infected.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 21 Jul 2011 14:53:03 EST</pubDate>
	 <guid isPermaLink="false">news230478701</guid>
	 
</item>
<item>
     <title>1 in 4 new HIV infections in Ontario are among women: study</title>
   	 <description>Despite significant clinical advances in HIV care, an estimated 25 per cent of new HIV infections in Ontario from 2006 to 2008 were among women, according to a health study by researchers from the Institute for Clinical Evaluative Sciences (ICES) and St. Michael's Hospital. The researchers say 93 per cent of new infections among women are acquired through sexual transmission and seven per cent through injection drug use. About 60 per cent of newly infected women are immigrants. The findings, the latest from the POWER (Project for an Ontario Women's Health Evidence-Based Report) study, suggest targeted prevention and intervention efforts are necessary to eliminate gaps and inequities in care for HIV patients.</description>
     <link>http://medicalxpress.com/news/2011-06-hiv-infections-ontario-women.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 01 Jun 2011 04:19:54 EST</pubDate>
	 <guid isPermaLink="false">news226120719</guid>
	 
</item>
<item>
     <title>Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners</title>
   	 <description>Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by taking oral antiretroviral medicines when their immune systems were relatively healthy, according to findings from a large-scale clinical study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.</description>
     <link>http://medicalxpress.com/news/2011-05-hiv-infected-people-antiretrovirals-significantly-transmission.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 12 May 2011 11:43:02 EST</pubDate>
	 <guid isPermaLink="false">news224419358</guid>
	 
</item>
<item>
     <title>Sexual transmission of insect-borne virus</title>
   	 <description>(PhysOrg.com) -- Little did Brian Foy know that when he came home from a scientific research trip and had sex with his wife that that sexual act would create virological history.  A study just released in Emerging Infectious Diseases presents the case of probable sexual transmission of the Zika virus.</description>
     <link>http://medicalxpress.com/news/2011-04-sexual-transmission-insect-born-virus.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 07 Apr 2011 12:51:35 EST</pubDate>
	 <guid isPermaLink="false">news221399472</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/clilkjgfpboard-1.jpg" width="90" height="90" />
</item>


</channel>
</rss>
